VANCOUVER, BC, Jan. 5, 2022 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSX: NUMI), a mental health care
company advancing innovative treatments and safe, evidence-based
psychedelic-assisted therapies, will release its financial
results for the quarter ended November 30,
2021, after market close on Thursday,
January 13, 2022.
Interested parties are invited to participate in the Company's
Q1 2022 results conference call and webcast, occurring on the same
day, at 5:30 p.m. Eastern time /
2:30 p.m. Pacific time. During the
call, Numinus executives will review the Company's performance and
recent initiatives, and answer questions from analysts.
To listen to the live webcast, please register at:
https://event.on24.com/wcc/r/3574506/6105A28282486D6F95F7834E9C5632E2
The webcast will also be archived on the Events and
Presentations page of Numinus' Investor Relations website:
https://www.investors.numinus.com/events-and-presentations
To participate in the live conference call, please use the
following dial-in information:
- 1 (833) 989-2968 (Toll-free North
America)
- 1 (236) 714-4028 (International)
- Please ask to participate in Numinus' Q1 2022 Results Call. To
avoid any delays in joining the call, please dial in at least five
minutes prior to the call start time. If prompted, please provide
conference passcode 2670376.
A replay of the conference call can also be accessed after
8:30 p.m. Eastern time / 5:30 p.m. Pacific time on Thursday, January 13,
2022, at 1-800-585-8367 or 1-416-621-4642 (using passcode 2670376).
The replay will be available until January
27, 2022.
About Numinus
Numinus Wellness helps people to heal
and be well through the development and delivery of innovative
mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model – including
psychedelic production, research and clinic care – is at the
forefront of a transformation aimed at healing rather than managing
symptoms for depression, anxiety, trauma, pain and substance use.
At Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice and building the
foundation for a healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter,
and Instagram.
Forward-Looking Statements
Statements and other
information contained in this press release about anticipated
future events constitute forward-looking statements.
Forward-looking statements are often, but not always, identified by
the use of words such as "seek", "anticipate", "believe", "plan",
"estimate", "expect" and "intend" and statements that an event
"may", "will", "should", "could" or "might" occur or other similar
expressions. Forward-looking statements are subject to risks and
uncertainties and other factors that could cause actual results to
differ materially from those contained in the forward-looking
statements. Forward-looking statements are based on estimates and
opinions of management at the date the statements are made. The
Company does not undertake any obligation to update forward-looking
statements even if circumstances or management's estimates or
opinions should change except as required by applicable laws.
Investors should not place undue reliance on forward-looking
statements.
View original
content:https://www.prnewswire.com/news-releases/numinus-to-host-q1-2022-results-conference-call-on-january-13-2022-301454334.html
SOURCE Numinus Wellness Inc.